CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | Patel Snehal CEO and CFO | Option exercise · Series D Preferred Stock | −45,328 | 0 | ||
| 2020-09-29 | Patel Snehal CEO and CFO | Option exercise · Series D Preferred Stock | −43,072 | 0 | ||
| 2020-09-29 | Patel Snehal CEO and CFO | Other acquisition · Series D Preferred Stock | +14,401 | 14,401 | ||
| 2020-09-29 | Patel Snehal CEO and CFO | Other acquisition · Series D Preferred Stock | +6,929 | 6,929 | ||
| 2020-09-29 | Patel Snehal CEO and CFO | Other acquisition · Series D Preferred Stock | +7,292 | 7,292 | ||
| 2020-09-29 | Patel Snehal CEO and CFO | Option exercise · Series D Preferred Stock | −14,401 | 0 | ||
| 2020-09-29 | Patel Snehal CEO and CFO | Option exercise · Series D Preferred Stock | −6,929 | 0 | ||
| 2020-09-29 | Patel Snehal CEO and CFO | Option exercise · Series D Preferred Stock | −7,292 | 0 | ||
| 2020-09-29 | Hallock Kenneth Director | Option exercise | +18,727 | 276,095 | ||
| 2020-09-29 | Hallock Kenneth Director | Option exercise | +18,727 | 294,822 | ||
| 2020-09-29 | Hallock Kenneth Director | Option exercise | +79,121 | 386,671 | ||
| 2020-09-29 | Hallock Kenneth Director | Option exercise · Series B Preferred Stock | −18,727 | 0 | ||
| 2020-09-29 | Hallock Kenneth Director | Option exercise · Series C Preferred Stock | −18,727 | 0 | ||
| 2020-09-29 | Hallock Kenneth Director | Option exercise · Series D Preferred Stock | −79,121 | 0 | ||
| 2020-09-29 | Hallock Kenneth Director | Other acquisition · Series D Preferred Stock | +12,728 | 12,728 | ||
| 2020-09-29 | Hallock Kenneth Director | Option exercise · Series D Preferred Stock | −12,728 | 0 | ||
| 2020-09-29 | McWilliams David Director | Option exercise | +152,604 | 599,583 | ||
| 2020-09-29 | McWilliams David Director | Option exercise | +7,663 | 607,246 | ||
| 2020-09-29 | McWilliams David Director | Option exercise | +3,746 | 610,992 | ||
| 2020-09-29 | McWilliams David Director | Option exercise | +7,609 | 618,601 |
Page 9 of 10 · 190 trades